2021
DOI: 10.1148/radiol.2021203341
|View full text |Cite
|
Sign up to set email alerts
|

Imaging the Substantia Nigra in Parkinson Disease and Other Parkinsonian Syndromes

Abstract: which results in a trilaminar pattern (Fig 1). The use of 3-T SWI has yielded similar nigrosome 1 findings (Fig 2, A-D) (22)(23)(24)(25)(26)(27)(28). Across the literature, different terms, such as swallow tail sign, SN dorsolateral hyperintensity, or simply nigrosome 1, refer to nigrosome 1 appearance. Nigrosome Imaging in PDOn both 3-and 7-T MRI scans, patients with PD show nigral hyperintensity loss (15)(16)(17)(18)(19)(20)(21)(22)(23)(24)(25)(26)(27)(28). This loss of nigral hyperintensity reflects signal … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
34
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 84 publications
(35 citation statements)
references
References 179 publications
0
34
0
1
Order By: Relevance
“…However, such associations had neither been assessed using neuropathologic evaluations nor in the context of clinical AD. Additional studies combining FDG-PET with imaging modalities aimed to evaluate SN degeneration in-vivo (44)(45)(46)(47) would be of great interest for replicating and studying these associations in larger observational cohorts.…”
Section: Discussionmentioning
confidence: 99%
“…However, such associations had neither been assessed using neuropathologic evaluations nor in the context of clinical AD. Additional studies combining FDG-PET with imaging modalities aimed to evaluate SN degeneration in-vivo (44)(45)(46)(47) would be of great interest for replicating and studying these associations in larger observational cohorts.…”
Section: Discussionmentioning
confidence: 99%
“…[1][2][3][4][5] The method has been most broadly applied in research studies of neurodegenerative illnesses such as Parkinson's disease and Alzheimer's disease as a marker of degeneration of these nuclei. 2,3,6,7 More recently it has been applied in psychiatric conditions, where the NM-MRI signal has been shown to correlate to important aspects of psychopathology, consistent with evidence that the signal may assay aspects of the function of these neurotransmitter systems, even in the absence of neurodegeneration. 1,8,9 Many research studies support the potential of NM-MRI as a neuroimaging biomarker that could prove useful in clinical applications such as diagnosis or treatment of neurodegenerative and psychiatric disorders.…”
Section: Introductionmentioning
confidence: 67%
“…Mounting evidence indicates that immune dysfunction is involved in the pathogenesis of PD. The physiological function of the axon guidance pathway includes neuronal network formation during central nervous system development and the maintenance and plasticity of neural synapses (Bae et al, 2021). Abnormal axon-guidancemolecule signaling can lead to loss of connectivity and eventually trigger PD (Lin et al, 2009;Tomiyama, 2011).…”
Section: Discussionmentioning
confidence: 99%